Critical Therapeutics Inc. (CRTX) CFO David Price sells 150,000 Shares

Author's Avatar
Sep 03, 2009
CFO of Critical Therapeutics Inc. (CRTX, Financial) David Price sells 150,000 shares of CRTX on 09/03/2009 at an average price of $7.05 a share.

CORNERSTONE THERAPEUTICS is a specialty pharmaceutical company focused on acquiring developing and commercializing prescription products for the respiratory market. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a deep late-stage clinical pipeline with six regulatory approval submissions expected between 2009 and 2010. The Company's commercial strategy is to grow market share for its currently marketed products using its sales and marketing capabilities acquire non-promoted or underperforming branded pharmaceutical products and implement life cycle management techniques to maximize the value of its currently marketed products newly acquired products and product candidates that are in development. Critical Therapeutics Inc. has a market cap of $175.4 million; its shares were traded at around $7.07 with a P/E ratio of 6.1 and P/S ratio of 2.7.

Recent Trades of Critical Therapeutics Inc. by Directors and Officers:
  • Sell: Director Alastair Stuart Mcewan sold 8,141 shares of CRTX stock on 06/19/2009 at the average price of $9; the price of the stock has decreased by 21.44% since.

  • Sell: Director Alastair Stuart Mcewan sold 46,704 more shares of CRTX stock on 06/15/2009 at the average price of $8.51; the price of the stock has decreased by 16.92% since.

  • Sell: Director Alastair Stuart Mcewan sold 7,165 more shares of CRTX stock on 06/11/2009 at the average price of $8.5; the price of the stock has decreased by 16.82% since.

  • Sell: Director Alastair Stuart Mcewan sold 57,031 more shares of CRTX stock on 06/09/2009 at the average price of $8.08; the price of the stock has decreased by 12.5% since.

  • Sell: GENERAL COUNSEL and EVP LEGAL Scott B Townsend sold 44,972 shares of CRTX stock on 05/18/2009 at the average price of $6.48; the price of the stock has increased by 9.1% since.